BlueZone. ANESTHETIC COLLECTION SERVICE. Saving our neighborhoods every day.

Blue-Zone Technologies Ltd. News Releases

April 29, 2020
Blue-Zone Technologies Ltd. Receives Drug Approval From Health Canada for Its Branded Generic DESFLURANE, USP. [CLICK HERE]
Businesswire
Blue-Zone prepares for local production and commercial launch of Desflurane, safeguarding access to this critical drug for all Canadians and providing significant costs savings to hospitals

TORONTO, On. – April 29, 2020: Blue-Zone Technologies Ltd. announces receipt from Health Canada of a Drug Identification Number (DIN) for DESFLURANE, USP, an important drug used for general anesthesia. The DIN permits Blue-Zone to produce and commercially launch its branded generic drug. Desflurane makes up approximately one-third of the global inhalation anesthesia market, which, according to a recent Global Market Insights report, is projected to reach USD $1.9 billion by 2025.

This is the first known approval in the world for a drug produced using a distillation-based process. Blue-Zone created and then globally patented its unique processes for capturing and processing the costly and acutely environmentally harmful anesthetic gases used in surgeries. These gases were previously vented directly into the outside community.

[Click title to read more]


June 11, 2019
The Anesthetic Gasses Hurting the Environment From Operating Rooms [CLICK HERE]
CBC TV "The National"
Blue-Zone is featured on the CBC News television program "The National". [Click title to view news report]

November 7, 2016
Blue-Zone Technologies Granted Canadian Patent for Central Collection of Anesthetic Gases, Securing their Leading Position in the Sector [CLICK HERE]


CONCORD, ON, Nov. 7, 2016 /CNW/ - Blue-Zone Technologies Ltd. ("Blue-Zone"), a multi-award-winning cleantech company, is pleased to announce the grant of an additional patent in Canada: Canadian Patent No. 2,772,776, granted October 25, 2016, Adsorbent and Systems and Methods for Recovery of Halogenated Hydrocarbons, with a 2009 priority date. This relates to Blue-Zone's Centralsorb® Anesthetic Recovery System, which enables recovery of waste anesthetic gases from a central location in a hospital. Earlier this year Blue-Zone announced a similar patent had been granted to it in the United States.

"Our technology enjoys a global profile, and the awarding of this patent reinforces Blue-Zone's position of worldwide leadership in the halogenated anesthetic gas collection, reclamation, and production sectors. As we are a Canadian company, the Canadian patent grant is extra special for us," says Dusanka Filipovic, P.Eng., co-inventor of Centralsorb®, and Founder, Vice Chair and President of the company. "Blue-Zone's patented technologies are a Cradle-to-Cradle® solution to a global problem, and align with today's international mandate by reducing a hospital's carbon footprint, protecting public health, and building valuable anesthetic production capacity, which is beneficial for the environment and mankind..."

[Click title to read more]


March 14, 2016
Blue-Zone Technologies Awarded Additional US Patent for Central Collection of Anesthetic Gas, Securing Their Leading Position in the Sector [CLICK HERE]
Blue-Zone Technologies Awarded Additional US Patent for Central Collection of Anesthetic Gas, Securing Their Leading Position in the Sector

CONCORD, On. – March 14, 2016: Blue-Zone Technologies Ltd., a multi-award-winning cleantech company, is pleased to announce the allowance of an additional patent in the United States (related to US Patent Application No. 14/717,217). This patent allowance, with a 2009 priority date, relates to Blue-Zone’s Centralsorb® Anesthetic Recovery System, which enables recovery of waste anesthetic gases from a central location in a hospital.

During a typical surgery, 95% of the halogenated anesthetic drugs used are vented into the atmosphere. These anesthetics are very aggressive greenhouse gases. In North America, there are approximately 54,000 operating rooms, and annually those rooms can release the CO2 equivalent to well over two million cars. These toxic gases are stable, seven times heavier than air, tend to linger and amass in the area around a hospital for decades, and are an officially recognized occupational health and safety hazard. The use of anesthetic gases is forecast to grow globally by 10% to 15% per year, providing Blue-Zone’s patented technology with a significant growth opportunity.

Centralsorb®, as with Blue-Zone’s other patented system, Deltasorb®, prevents the release of these greenhouse gases into the atmosphere and offers a significant value-add to merely collecting and stockpiling, and/or incinerating the waste. These captured anesthetics are subsequently extracted, liquefied and used as raw material in the production of new, validated generic anesthetics at Blue-Zone’s facility. This ability to reprocess the recovered halogenated anesthetics – which is unique to Blue-Zone and not provided by any other company, worldwide – offers additional economic and security of supply benefits for hospitals that use Blue-Zone’s patented technology...

[Click title to read more]


March 1, 2011
Blue-Zone Video Profile now seen on YouTube [CLICK HERE]
"Blue-Zone Technologies Ltd. of Concord, Ontario, Canada is very pleased to release its first video featuring the Deltasorb® anesthetic gas recycling service, sharing the testimonials of leading doctors and cutting-edge environmental executives who have adopted the technology at major hospitals in Southern Ontario..."

Full-length video can be viewed here: YouTube Video

[Click title to read more]


Testimonials

Dr. Gerry O'Leary, MB, FRCPC "We are pleased to collaborate with Blue-Zone, not only because the technology is innovative but also because it can extend the useful life cycle of a...
image description

Blue-Zone Story

Deltasorb® Anesthetic Collection Service Launches New Website

Blue-Zone Technologies is pleased to announce the launch of its new Deltasorb® Anesthetic Collection Service website. The website is a resource...

FAQ

15) What happens if the cap is lost or not closed properly when not in use?

The cap is cosmetic. The canister will not 'leak' unless subjected to controlled operating conditions similar to those in use at our production facili...

Contact Info

by
14-84 Citation Drive Concord (Toronto), ON Canada L4K 3C1
Tel: (905) 761-1224 Fax: (905) 761-3371
Email: health@bluezone.ca

Articles of Interest

  • Blue Zone

    Blue-Zone Receives Drug Approval From Health Canada for Its Branded Generic Desflurane, USP.

    Blue-Zone prepares for local production and commercial launch of Desflurane, safeguarding access to this critical drug for all Canadians and providing significant cost savings to hospitals. ...

  • Blue Zone

    The Anesthetic Gasses Hurting the Environment From Operating Rooms

    Blue-Zone is featured on CBC television program "The National"....

  • Blue Zone

    Green Solutions - A Greener Way to Get Anesthetized

    Blue-Zone is featured in the Globe and Mail....